Pubertal Blockade and Subsequent Gender-Affirming Therapy
- PMID: 36318212
- PMCID: PMC9793415
- DOI: 10.1001/jamanetworkopen.2022.39763
Pubertal Blockade and Subsequent Gender-Affirming Therapy
Comment on
-
Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.JAMA Netw Open. 2022 Nov 1;5(11):e2239758. doi: 10.1001/jamanetworkopen.2022.39758. JAMA Netw Open. 2022. PMID: 36318207 Free PMC article.
References
-
- Rafferty J; COMMITTEE ON PSYCHOSOCIAL ASPECTS OF CHILD AND FAMILY HEALTH; COMMITTEE ON ADOLESCENCE; SECTION ON LESBIAN, GAY, BISEXUAL AND TRANSGENDER HEALTH AND WELLNESS. Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents. Pediatrics 2018;142(4):e20182162. - PubMed
-
- Kremen J, Williams C, Barrera EP, et al. Addressing legislation that restricts access to care for transgender youth. Pediatrics. 2021;147(5). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
